Mukantayev K, Mukanov K, Zhylkibayev A. ROLE OF MONOCLONAL ANTIBODIES AGAINST THE PROGRAMMABLE DEATH (PD-1) RECEPTOR OF T-CELLS IN TARGETED THERAPY OF MELANOMA. Eurasian Journal of Applied Biotechnology [Internet]. 2018Jan.10 [cited 2024May1];(1). Available from: https://biotechlink.org/index.php/journal/article/view/75